Relief and NeuroRx Announce Partnership for Global Commercialization of RLF-100(TM) and Selection of Commercial Partners
RLF-100 (Aviptadil) is in advanced stages of phase 2b/3 development in the US
Rapid recovery of patients on ventilators and ECMO (extracorporeal membrane oxygenation) has been reported under FDA Emergency Use IND authorization at multiple clinical site... Biopharmaceuticals Relief Therapeutics, NeuroRx , Aviptadil, COVID-19
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news